Is the next 6 months going to see this company transform into a major player. I think so.

RNS Number:2840Z
International Medical Devices PLC
06 March 2006


. International Medical Devices gears up for NHS debut


International Medical Devices (IMD or "the Company") is delighted to announce
that initial production runs of its ClipOnTM "safe" needle device have begun for
delivery into the NHS and also South Africa.

Production is taking place at the Eastland Medical Systems plant in Portland,
Australia, following IMD's acquisition of the patents over a range of safe
devices from Eastland Technology Australia (ETA).

The NHS Purchasing and Supply Agency currently buys 136 million needles per
year, of which 50 per cent are 21 gauge needles. The total UK market is
estimated at approximately 200 million per year. IMD will initially target this
21 gauge market, i.e. 70 million needles. IMD, with its associate company EMS,
also intends to address the growing need for safe needles in sub-Saharan Africa
where HIV is causing such devastation. To this end it is working with the Nelson
Mandela Foundation. The World Health Organisation estimates that at least five
per cent of HIV has been contracted through the use of unsterile needles. IMD's
safe needles can be used once only and once retracted are fully secure.

Trials begin in five NHS Trust hospitals of IMD's ClipOnTM safe needle device
later this month and the needle buyer for the NHS Purchasing and Supply Agency
(PASA) has agreed to support the fast-track launch of the Company's products
into the Service for launch in April.

The Company's assessment of the UK, European, South African and Australian
markets indicates initial potential demand for the ClipOnTM safe retractable
needle is in the order of 300 million units annually. Volumes in excess of 100
million units are anticipated to substantially reduce production costs and open
up further markets.

Last month IMD reported that it has enjoyed an outstanding six months following
the acquisition of the medical distributor Meddis Ltd in September 2005, with
Meddis sales for last November up by 29 per cent over the same month in 2004 and
January sales up 46 per cent on 2005.

Chris Thomas, Chief Executive of IMD said: "We are now entering a period of
great activity and growth exactly in line with our stated strategy. We believe
we can make a very real and valuable contribution to the safety of healthcare
staff in the NHS with the introduction of our cost effective, safe needles. The
overall savings to the Service by eliminating days lost through needlestick
injuries - up to 100,000 each year - should be in the region of #10 million
annually".

Sounds like a very good buy to me, just a shame the market has not seen it like that. However when the award for the safty needle contract comes in they now have everything in place to accomodate it. This I would of thought would also assist in getting the contract.

Thanks to explosive and kimoldfield for your thoughts. Dont hold many shares (35K) but looking to keep for the next 12 months.

Good luck to all

RME is a distributor of medical devices and medical consumables. Its key
distribution agreements are with Welch Allyn, Ypsomed, Dr Comfort, Tyco, Medis
and Medicapteurs. In its last audited accounts to 31st March 2005, RME achieved
sales of 6.1 million generating profits before tax of 895,000. As at 31st
March 2005, RME had net assets of 2.15 million including cash of 300,000.



RME employs 19 people and has developed into an efficient, profitable,
disciplined sales organisation. Of the 4 directors/shareholders, two will be
joining the main board of IMD Plc, John Butler, Chairman and founder of RME and
Matthew Root, its managing director.



RME sells into every NHS trust hospital in the UK, and also wins regular central
tenders from the NHS Purchasing and Supply Agency. Sales are also made to
various ambulance services, the Ministry of Defence and to the private health
sector. IMD Plc will now have the channel to market to supply its range of 'safe
' needle devices and an exclusive wider product range that includes beds and
hospital furniture, speciality needles, thoracic drains and sundry disposables.
The IMD Plc Board is satisfied that the acquisition of RME on top of the
acquisition of Meddis Ltd last September, will provide the Group with the sales
skills, logistic know-how and management expertise in the medical device sector
to rapidly grow revenues and profits in the years ahead.

Might see this move up on Monday. The following article was in the Telegraph on Saturday

International Medical Devices

Safety needle firm International Medical Devices has not had the best of runs since Questor first wrote about it around Christmas.

The shares have fallen from 8.4p last year to 6.62p this year, which is disappointing.

It is especially galling as Questor's prediction on March 4 that IMD would buy a larger distribution company came true on Wednesday.

It bought Response Medical Equipment for 6.3m, which will give IMD 8.5m of sales and profit before tax of 800,000 on a pro-forma basis. The company now has a powerful in-road into the NHS and should be able to build on this.

With IMD's product range, and RME's distribution skills, the company is now far better equipped than ever to make some real money.

The market as yet has not woken up to the transforming power of this acquisition, and existing shareholders should continue to hold on in there.

Hold.

Well I decided to add another 10K looking for this to reach new highs if/when the NHS contract is announced.

Has to be a good investment Coop, I will top up when I can; put my weekend pocket money in more SUN this am. (It will shine one day, just as INT must surely do!)
kim

Hi Kim

Not a bad day today, volume was good with 1,200,000 shares traded and a tick up :))

Dont know too much about SUN but will have a look tonight results looked quite good though after a quick scan.

Nice bit of info

http://www.eastlandmedical.com.au/Uploads/Images/ClipOn%20Announcement%20170106.pdf

Still trying to figure all this out but I suspect that we have some form of income if these needles are used in Africa. If this is the case -

IMD, with its associate company EMS,
also intends to address the growing need for safe needles in sub-Saharan Africa
where HIV is causing such devastation. To this end it is working with the Nelson
Mandela Foundation. The World Health Organisation estimates that at least five
per cent of HIV has been contracted through the use of unsterile needles. IMD's
safe needles can be used once only and once retracted are fully secure.

Trials begin in five NHS Trust hospitals of IMD's ClipOnTM safe needle device
later this month and the needle buyer for the NHS Purchasing and Supply Agency
(PASA) has agreed to support the fast-track launch of the Company's products
into the Service for launch in April.

The Company's assessment of the UK, European, South African and Australian
markets indicates initial potential demand for the ClipOnTM safe retractable
needle is in the order of 300 million units annually. Volumes in excess of 100
million units are anticipated to substantially reduce production costs and open
up further markets.

Then the following can only be good news but I am not 100% sure.

http://www.eastlandmedical.com.au/Uploads/Images/Secures%20South%20African%20Distributor%20110406.pdf

Any ideas anybody

Coops. Am I right that IMD has acquired the Technology Patents from ETA and the Distribution
Rights from EMS in respect of territories outside the Southern Hemisphere, specifically North America, UK and most of Europe and would they therefore need to further acquire rights to distribute in South Africa: or do you feel that it is already covered - if so, then as you say it can only be good news. (Not usually up this late, been out tasting the malt,barley & hops - hence probably not thinking clearly anyway!!)
kim

Hi Kim, hope the head is ok in the morning for you.

I am not too sure, If they did not have the rights for South Africa then why have INT mentioned it in their RNS??

Anyone else know?

One thing I did find out was that the cost of a needle is 25 australian cents which equals about 10p a needle. Sounds ok to me

My head is fine thanks Coop, we have a very high standard of beer here - never have a hangover! ;-) I think you are right, South Africa is mentioned a few times here and there, I would imagine also that EMS would encourage INT to distribute wherever they can. 10p a needle - that's a lot of millions of 10ps!
kim

Overhang still in place, can still buy under midprice even after 3million buys today....

Another 400,000 odd in buys again and you can still buy under mid but at least the price ticked up on. Volume still looking good as well

Just incase anybody wanted to check their website out it is at

http://imd-plc.com

and if you go to their profile you can download their prospectus.

Nice to see Eastland expanding into Africa and dual listing. Things must be going :))

IMD next for the news?

http://www.asx.com.au/asx/statistics/announcementSearch.do?method=searchByCode&releasedDuringCode=W&issuerCode=EMS

Well I am still holding onto these last bit of news is that they brought all available clip on needles from Aus (5 mil in total)

I wonder why

Time to get into these
MMs selling them under mid, but then they dont know whats coming ;)

Ok pommy what do you know??

Well this may help

Well things could be hotting up soon

http://www.rmcapital.com.au/pdfs/EMS_RMR_7_12_2006.pdf

Mentions about acquisitions in Holland, France, Spain and the US. There is alot of other positives in the report with regards to ClipOn sales.

http://www.rmcapital.com.au/pdfs/EMS_RMR_7_12_2006.pdf

Well looks as if this could be the year for INT


Well I have been doing a little more thinking about todays RNS and if you stick it with the release from Eastlands then the you might see why they have sold them

In the Eastland release they state that the reason for selling is to 'Quickly implement the planned South African manufacturing operation bringing forward the mass production of the ClipOn needle'

Now as far as I am aware INT are the only company near to launching this product especially now that they have the CE mark for it. In the RNS informing us of the CE marking they said this

To receive the CE marking on our ClipOn safe needle is a
significant step forward. ClipOn can become one of the principal products in
driving the Company's organic growth to help reach our goal of becoming one of
the major medical distributors in the UK and Europe. We have already received
orders from the NHS for ClipOn.

Orders already received!!! They have already brought the entire production for the year from Eastlands Australian manufacturer of 5 million needles but that will not last long, with around 100million needles a year required just for the UK

I think Eastlands have had to sell to raise the funds to meet the new contracts from the NHS.

Good luck to all holders. As del boy says, this time next year....well I live in hope :-)